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Abstract
Tea polyphenolics have been suggested to possess blood glucose lowering prop-
erties by inhibiting sugar transporters in the small intestine and improving insulin 
sensitivity. In this report, we studied the effects of teas and tea catechins on the 
small intestinal sugar transporters, SGLT1 and GLUTs (GLUT1, 2 and 5). Green 
tea extract (GT), oolong tea extract (OT), and black tea extract (BT) inhibited glu-
cose uptake into the intestinal Caco-2 cells with GT being the most potent inhibitor 
(IC50: 0.077 mg/mL), followed by OT (IC50: 0.136 mg/mL) and BT (IC50: 0.56 mg/
mL). GT and OT inhibition of glucose uptake was partial non-competitive, with an 
inhibitor constant (Ki) = 0.0317 and 0.0571 mg/mL, respectively, whereas BT was 
pure non-competitive, Ki = 0.36 mg/mL. Oocytes injected to express small intestinal 
GLUTs were inhibited by teas, but SGLT1 was not. Furthermore, catechins present 
in teas were the predominant inhibitor of glucose uptake into Caco-2 cells, and gal-
lated catechins the most potent: CG > ECG > EGCG ≥ GCG when compared to 
the non-gallated catechins (C, EC, GC, and EGC). In Caco-2 cells, individual tea 
catechins reduced the SGLT1 gene, but not protein expression levels. In contrast, 
GLUT2 gene and protein expression levels were reduced after 2 hours exposure to 
catechins but increased after 24 hours. These in vitro studies suggest teas containing 
catechins may be useful dietary supplements capable of blunting postprandial gly-
caemia in humans, including those with or at risk to Type 2 diabetes mellitus.
K E Y W O R D S
catechins, facilitative glucose transporters (GLUTs), glucose uptake, sodium-dependent glucose 
transporter (SGLT1), tea extract
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1 |  INTRODUCTION
Tea is produced from the buds and leaves of the plant 
Camellia sinensis (L.) O. Kuntze and is one of the most 
widely consumed beverages in the world. According to dif-
ferent manufacturing processes, tea is generally classified 
into three types: non-fermented tea, partially fermented 
tea, and fully fermented tea.1 Green tea is a non-fermented 
type and contains 20%-42% catechins (dry weight), which 
are flavonoid polyphenols that are considered to have num-
ber of potential health benefits, including a reduced risk of 
certain cancers, cardiovascular disease, and Type 2 diabetes 
mellitus (T2DM).2 During black tea (fermented tea) manu-
facture, catechins in fresh leaves are oxidized into quinones 
by polyphenol oxidase and condensed to form theaflavins 
and thearubigins,3 which results in a significant decrease of 
catechins (3%-10% of dry weight). Oolong tea is partially 
fermented, and so catechin content is intermediate between 
green and black teas (8%-20% of the total dry matter).
Diabetes mellitus is a chronic metabolic disorder charac-
terized by a persistent increase in blood glucose concentra-
tions above normal values (ie, hyperglycemia). Poor glycemic 
control in people with diabetes is associated with an increased 
risk in micro- and macrovascular complications, such as reti-
nopathy and cardiovascular disease, respectively.4,5 T2DM is 
a serious public health issue both in developed and develop-
ing countries, and it has become a global epidemic with more 
than a doubling of people with this metabolic disorder in the 
last 25 years.6 The first line of treatment of T2DM patients, 
in addition to changes to dietary and exercise regimens, is 
the use of oral antihyperglycemic agents, such the biguanide 
metformin (the most commonly used), sulfonylureas, α-glu-
cosidase, and dipeptidyl peptidase-4 inhibitors, and gluca-
gon-like peptide 1, an incretin mimetic.7 However, although 
these medications are known to ameliorate glycemic control, 
a range of side effects can occur including nausea, gastroin-
testinal symptoms (eg, diarrhea, bloating), and increased risk 
of liver disease and bladder cancer.8 Moreover, there are sub-
stantial concerns about the increase in global health expendi-
ture associated with diabetes and affordability of medication, 
especially in developing countries.9 In response to these con-
cerns, there has been an increased interest in investigating the 
use of antidiabetic components of foods and drinks as dietary 
adjuncts for the management and prevention of T2DM.10-12 
The blood glucose lowering property of tea phenolics has re-
ceived particular attention.
The consumption of tea flavonoids and other polypheno-
lic compounds are reported to have health benefits in indi-
viduals with or at risk of T2DM, for example, by improving 
glucose tolerance, enhancing insulin sensitivity, and reduc-
ing oxidative stress.13,14 The effects of tea on postprandial 
glycaemia has been attributed to tea polyphenolics, mainly 
the catechins ((+) catechin, (−) epicatechin, (−) epicatechin 
gallate, (−) epigallocatechin, and (−) epigallocatechin gal-
late),15 which are reported to inhibit the digestion kinetics of 
available carbohydrates (eg, starch) and glucose absorption 
in the proximal gut.2,16-18 Tea and individual catechins are ef-
fective inhibitors of intestinal α-amylase and α-glucosidase, 
delaying starch and disaccharide digestion, respectively.19-21 
Epicatechin gallate (ECG) is also a potent inhibitor of glu-
cose uptake into intestinal cells and a competitive inhibitor 
of the Na+ dependent glucose transporter (SGLT1), which 
is expressed on the apical membrane of small intestinal en-
terocytes.22,23 However, the effects of tea catechins on the fa-
cilitative sugar transporters expressed in the small intestine 
are less well understood. GLUT2 is a facilitative sugar trans-
porter expressed on the basolateral membrane of the entero-
cyte and is responsible for the exit of glucose and fructose 
from the enterocyte into portal blood. Under conditions of 
high simple sugar feeding and in diabetes, GLUT2 is also ex-
pressed on the apical membrane, contributing to increased in-
testinal sugar absorptive capacity.24 In experimental diabetes, 
GLUT1 has also been detected on the apical membrane of 
enterocytes.25 The facilitative fructose transporter, GLUT5, 
is also present in the small intestine, expressed on the brush 
border membrane (BBM) and responsible for the absorption 
of dietary fructose from the lumen into the enterocyte.26 
Thus, the small intestinal facilitative sugar transporters are 
also potential therapeutic targets for lowering blood sugar 
levels.
In the present study, we investigated the acute effects of 
green, oolong, and black tea extracts on reducing glucose up-
take in human intestinal Caco-2 cells, a well-established in 
vitro model of the human enterocyte, which expresses many 
of the known intestinal sugar transporters, including SGLT1, 
GLUT1, GLUT2, GLUT3, and GLUT5.27-29 Xenopus oo-
cytes, which express individual intestinal sugar transporters, 
were also used to identify the transporters inhibited by the 
tea samples. In Caco-2 cells, we also studied the short- and 
long-term effects of individual tea catechins on SGLT1 and 
GLUT2 gene and protein expression profiles.
2 |  MATERIALS AND METHODS
2.1 | Materials
Green, oolong, and black teas were purchased from 
Changchen Tea Factory in Hubei Province, Anxi Jinghe Tea 
Company in Fujian Province and Chenyuan Tea Factory 
in Yunnan Province, China, respectively. The teas were 
all grown in the same region and harvested between April 
23rd and 25th. Differences in catechin content are therefore 
solely due to the manufacturing process, not the harvest 
location, the time of year or different growth conditions.30 
They were identified as three-grade tea according to the Tea 
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Quality Standard of China (GB/T 14456-93, GB/T19598-
2006, and GB/T 13  738.1-2008, respectively). Stock cul-
tures of Caco-2 cells (TC7 clone-human adenocarcinoma) 
were obtained from Dr Edith Brot-Laroche, INSERM, Paris, 
France. The standards of (−)-epicatechin (EC), (+)-catechin 
(C), (−)-epigallocatechin (EGC), (+)-gallocatechin (GC), 
(−)-epicatechin gallate (ECG), (+)-catechin gallate (CG), 
(−)-epigallocatechin gallate (EGCG), (+)-gallocatechin 
gallate (GCG), and theaflavin (TF) were purchased from 
Sigma-Aldrich Chemical Reagent Co. Ltd., UK; Dulbecco’s 
Modified Eagle Medium (DMEM), non-essential amino 
acids, and trypsin were obtained from Invitrogen Ltd., UK; 
Fetal Bovine Serum was purchased from PAA Laboratories 
GmbH, Austria; Penicillin/streptomycin was purchased from 
Hyclone Laboratories Inc; Plasmocin was obtained from 
Corporate Headquarters, USA; Biodegradable Scintillation 
Solution was obtained from Atlanta, Georgia, USA. D-[14C] 
glucose was purchased from Perkin Elmer, Boston, USA. 
Radio immunoprecipitation assay (RIPA) lysis buffer and 
phenylmethanesulfonyl fluoride (PMSF) were obtained 
from Beyotime (Shanghai, China). BCA protein assay kit 
was purchased from Nanjing Jiancheng Bioengineering 
Institute (Nanjing, China). Polyvinylidene Fluoride (PVDF) 
membranes were obtained from Atto Co. (Tokyo, Japan). 
Rabbit SGLT1 antibody and rabbit GLUT2 antibody were 
purchased from Abcam (Cambridge, UK). Enhanced chemi-
luminescence (ECL) reagents, mouse β-actin antibody, goat 
anti-rabbit, and goat anti-mouse secondary antibody were 
all obtained from Proteintech Group (Wuhan, China). Rat 
GLUT1 (rGLUT1) was obtained from GW Gould (Dartmouth 
Medical School, Hanover, New Hampshire, USA) in the vec-
tor pSP64T containing a 1.58  kb insert and an ampicillin 
gene). Human GLUT2 and rat GLUT5 were obtained as a 
plasmid construct from GI Bell and CF Burant (University 
of Chicago, USA). Rat SGLT1 (Clone ID: 7129017) was ob-
tained from Open biosystems (Thermo Scientific, GmBH). 
All other chemicals used were analytical grade.
2.2 | Methods
2.2.1 | Preparation of the tea extracts
The tea extracts (TEs) were prepared according to the method 
as described previously.31 Briefly, 100 g of each tea sample 
was ground (milled) and subjected to three successive ex-
tractions with 1200 mL of distilled water at 100°C. In every 
extraction, the tea was left to infuse for 10 minutes at 60°C. 
The three aqueous extracts were pooled and filtered through 
filter paper. The filtrates were concentrated using a vacuum 
rotary evaporator at 45°C, and then, freeze-dried. The tea ex-
tract powders were stored at −80°C before being dissolved in 
water/1% of DMSO.
2.2.2 | Determination of catechins in TEs
Catechins were determined by high performance liquid chro-
matography (HPLC) at Finlay Tea Extracts Ltd, UK, as de-
scribed by in our previous work.32 Briefly, the tea extract 
powders (0.2 g) were resolved with 10 mL of 70% methanol 
(vol/vol), then, the solution was filtered through a 0.45 μm 
membrane. The separation was performed on an ODS re-
versed-phase column (4.6  mm i.d. × 250  mm, TC-C18, 
Agilent Technologies Inc, CA, USA) in an Agilent LC1260 
system (Agilent Technologies Inc, CA, USA) with a mobile 
phase (vol/vol) of 9% acetonitrile containing 0.2% of ethyl-
ene diamine tetraacetic acid (EDTA) and 2% of acetic acid, 
at a flow-rate of 1.0 mL/min. Catechins were detected using a 
diode array detector (DAD) at a wavelength of 278 nm.
2.2.3 | Cell culture
Caco-2 cells were cultured according to the method de-
scribed previously.33 Briefly, stock cultures of Caco-2 cells 
were seeded in 25 cm2 plastic flasks and cultured in a 95% 
of air/5% of CO2 atmosphere in DMEM, supplemented with 
10% of (vol/vol) fetal bovine serum, 1% of penicillin/strepto-
mycin, 1% of non-essential amino acids, 1% of L-glutamine, 
and 0.25 mg plasmocin. All experiments were carried out on 
cells between passage numbers 43 and 47 and the cells were 
seeded at a density of 4 × 104 cells/cm2 into 24-well plates 
(Costar, UK, Buckinghamshire, UK) and were grown for 
16-20 days.
2.2.4 | Glucose uptake by Caco-2 TC7 
cell monolayers
Caco-2 cells were grown to confluence. The cells were per-
mitted to come to room temperature for 15-30 minutes, then, 
washed three times with Krebs buffered salt solution (KBSS, 
pH 7.2-7.4; 137 mM of NaCl, 4.7 mM of KCl, 1.2 mM of 
K2HPO4, 1.5 mM of CaCl2, 1.2 mM of MgSO4, and 10 mM 
of HEPES). Caco-2 cells were incubated for 10 minutes at 
room temperature with tea extracts (dissolved in KBSS) or 
polyphenols (dissolved in DMSO, and then, diluted with 
KBSS) prior to experiments. Uptake was initiated by the ad-
dition of either the control or test solutions containing tracer 
D-[14C] glucose and the reaction was terminated after 2 min-
utes by aspiration of the uptake media (KBSS) followed by 
the addition of ice-cold phosphate-buffered saline (PBS). 
The monolayer was washed three times with ice-cold PBS, 
and then, solubilized in 0.5 mL of 200 mM NaOH for 1 hours 
at 37°C prior to scintillation counting. Aliquots of 400  μL 
were added to 2.5 mL of scintillation solution for radioac-
tivity determination (LS 6500 Multi-Purpose Scintillation 
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Counter, USA) and the remainder used for protein measure-
ment by Coomassie Brilliant Blue G (Protein Quantification 
Kit-Rapid, Sigma-Aldrich Chemical Reagent Co., Ltd., UK).
2.2.5 | Oocyte isolation and injection
Batches of Xenopus laevis oocytes were provided by the 
European Xenopus Resource Centre of the University of 
Portsmouth (UK). Oocytes were isolated from Xenopus lae-
vis and injected with mRNA using established methods.34 
Briefly, mature adult female frogs were anesthetized with 
3-amino benzoic acid ethyl ester (2 g/750 mL) in ice water. 
Frog ovaries were resected, and their ovarian lobes opened 
and incubated in OR-2 without calcium (5 mM of HEPES, 
82.5 mM of NaCl, 2.5 mM of KCl, 1 mM of MgCl2, 1 mM 
of Na2HP04, 100 μg/mL of gentamicin, pH 7.8) with colla-
genase type IV (2 mg/mL) for 30 minutes at 23°C. Individual 
oocytes were isolated and transferred to OR-2 containing 
1  mM of CaCl2 and maintained at 18-20°C until injection 
with mRNA. SGLT1 and GLUT cRNA were prepared by 
cutting plasmid vectors with appropriate restriction enzymes 
followed by in vitro transcription utilizing SP6, T7, or T3 
mMessage, mMachine (Ambion). cRNA was loaded into 
capillary pipettes generated using a micropipette puller (P-
77, Sutter, Novato, CA), and oocytes were injected using a 
pressure-controlled injector (Drummond Nanoject 11, USA). 
Injection volumes were between 30 and 50 nL, and cRNA 
concentration 0.5-1  mg/mL. Postinjected oocytes were in-
cubated at 20°C in OR-2 containing 1  mM of pyruvate 
with daily media changes. Experiments were performed on 
3-5 days after oocytes were injected with mRNA.
2.2.6 | Oocyte transport protocol
Transport of [14C] D-glucose, D-fructose and 2-[1,2- 3H] de-
oxy-D-glucose (26.2 mCi/mmol) was examined using groups 
of 10-20 oocytes injected to express SGLT1 and GLUTs or 
water injected sham oocytes at 23°C in OR-2 containing 
0.5-1 μCui/mL of labeled sugar with added non-labeled sugar 
for 10 minutes. After incubation in uptake medium, oocytes 
were immediately washed four times with ice cold PBS so-
lution. Phlorizin, tea extract, and individual catechins were 
added to the incubation medium as described in the results 
section. Individual oocytes were dissolved in 500 μL of 10% 
SDS and internalized radioactivity measured using scintilla-
tion spectrometry.
2.2.7 | Quantitative real time RT-PCR
The Caco-2 cells were seeded in 6-well plates (Corning 
Costar Co., NY, USA) at a density of 4 × 104 cells/cm2 and 
were cultured for 21  days. After incubation with different 
tea catechins (200 μM in full culture medium) for 2 hours or 
24 hours, the total RNA from the Caco-2 cells was isolated 
with a Total RNA Kit (Aidlab, Beijing, China). First-strand 
cDNA was synthesized using a cDNA synthesis Kit (Aidlab, 
Beijing, China). The gene expression of SGLT1 and GLUT2 
was examined by quantitative real-time PCR with the SYBR 
Green qPCR Mix (Aidlab, Beijing, China) in an ABI 7500 
Real-Time System (Applied Biosystems, USA). The reaction 
was carried out in a 10 μL RT-reaction mixture containing 
5 μL of 2× SYBR Green qPCR Mix, 0.2 μL of forward and 
reverse primers (10 μmol/μL), and de-ionized water to a final 
volume of 10  μL, and was performed under the following 
cycling conditions: an initial denaturing step of 10 minutes at 
95°C, followed by 40 cycles consisting of 5 seconds at 95°C 
and 34 seconds at 60°C.
All of the qPCR experiments were repeated three times. 
The data were analyzed using the 2−ΔΔCT method.35 All of 
the primers were synthesized by Sangon Biotech (Shanghai, 
China), and their sequences are depicted in Table 1.
2.2.8 | Western blot
After incubation with each of the tea catechins (200 μM in full 
culture medium) for 2 hours or 24 hours, 5 to 8 × 106 Caco-2 
cells were washed three times in precooled PBS buffer. The 
total lysate was prepared on ice by a 150  μL RIPA lysis 
buffer containing 1% of (vol/vol) PMSF. The lysates were 
centrifuged at 13,000  rpm for 20 minutes at 4°C, then, the 
protein-containing supernatant was collected, and the protein 
content determined using the BCA protein assay kit. Western 
blotting was performed according to standard techniques, as 
previously described.1 Briefly, the proteins were separated 
by SDS-polyacrylamide gel electrophoresis and were then 
transferred to a PVDF membrane in transfer buffer (contain-
ing 192 mM of glycine, 20 mM of Tris, and 20% of metha-
nol) at 4°C for 120 minutes at a constant 200 mA current. 
T A B L E  1  Primer sequences for qPCR assays
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After incubation, the membrane was blocked in Tris-buffered 
saline (TBST, containing 1.5 mM of Tris-base, 8.5 mM of 
Tris-HCl, 150 mM of NaCl, and 0.1% of SDS, pH 7.5) sup-
plemented with 5% of low-fat milk for 120 minutes. Then, 
the membrane was incubated with primary antibodies against 
SGLT1 or GLUT2 (1:2000) or β-actin (1:40  000) at 4°C 
overnight. After being washed with TBST, the membrane 
was incubated with peroxidase-conjugated secondary anti-
bodies for 60 minutes at room temperature. The protein blots 
were displayed using ECL reagents and quantified using 
BandScan software.
2.3 | Kinetic analysis of inhibition of glucose 
transport by tea extracts and by catechins
Data for the rates of 1, 3, and 6 mM of glucose uptake into 
Caco-2 cells in the presence and absence of 0-1  mg/mL 
of green tea extract were analyzed by fitting to the Eadie-
Hofstee (EH) and Hanes-Wolfe (HW) linear transforma-
tion of the Michaelis-Menten equation. For EH plots, v is 
plotted against v/[S] where v is the reaction velocity and 
[S] is the concentration of glucose. The slope of such plots 
is equal to -Km so that if plots obtained at different concen-
trations of inhibitor are parallel, that is, Km is unchanged, 
the inhibition is non-competitive. For HW plots, [S]/v is 
plotted against [S] and an intercept on the [S] axis is - Km. 
A common intercept (ie, an unchanged Km value) of plots 
with increasing slope is indicative of non-competitive inhi-
bition. Preliminary values of the kinetic parameters (Vmax, 
Km, Ki, and beta) were also calculated in SigmaPlot using 
an exploratory non-linear regression analysis function for 
non-competitive inhibition (partial). The nature of Green 
tea inhibition of glucose transport was studied more fully 
in further experiments by obtaining data that could be ana-
lyzed by modified Dixon plots 36 and plots for partial non-
competitive inhibition.37
Data for the rates of 1 mM of glucose uptake into CaCo-2 
cells in the presence of green, oolong, and black tea extracts 
ranging in concentration between 0 and 2 mg/mL and pure 
catechins (0-0.1 mg/mL; equivalent to 0-200 µM) were ana-
lyzed in Sigma Plot, and a best fit curve for each extract and 
pure catechin plotted using the non-linear regression analysis 
equation y = min + (max−min)/1 +  (x/IC50)-hillslope four 
parameter logistic curve.
For non-competitive inhibition, the equation for the mod-
ified Dixon plot36 is: v0/vi = (1+ [I]/Ki) where v0 and vi are 
the rates in the absence and presence of inhibitor concentra-
tions [I], respectively, and Ki is an inhibition constant. When 
inhibition is non-competitive the v0/vi plots intersect on the x 
axis at −Ki. IC50 values are readily estimated from v0/vi plots 
and when Ki and IC50 values are similar this provides good 
evidence that the mode of inhibition is pure non-competitive.
Partial non-competitive inhibition occurs when the pro-
tein-inhibitor complex is still partially active. For such be-
havior, Dixon 1/v against [I] and v0/vi against [I] plots are 
hyperbolic (non-linear). Linear analysis is possible, however, 
by the use of Whiteley plots, v0/(v0−vi) against 1/[I].37 For 
such plots, the intercept on the X axis equals −β/Ki where 
β = Vimax/Vmax; and Vimax is the maximum rate at infinite con-
centrations of inhibitor.
2.3.1 | Statistical analysis
Statistical analysis was performed using the appropriate 
statistical software (SAS Institute, NC). All the data were 
expressed as mean ± standard deviation (SD). Pearson’s cor-
relation analysis of tea catechin levels and the calculated IC50s 
for tea extracts was undertaken in Excel. The statistical sig-
nificances of the difference between the various groups were 
analyzed using Statistical Analysis with One-way ANOVA 
and the Bonferroni test for multiple comparison test correc-
tion. For comparison between the two groups, Student’s t test 
was used. Significant differences were accepted at P < .05.
3 |  RESULTS
3.1 | Effect of tea extracts on the glucose 
uptake in Caco-2 cells
The Caco-2 cell system is a colon carcinoma cell line that is a 
well-established model of the human enterocyte. During cell 
culture the cells differentiate to produce a BBM and basolat-
eral membrane that express many of the nutrient transporters 
found in the gut in vivo. SGLT1 has been detected on the 
apical membrane and GLUT5 and GLUT2 on both the baso-
lateral and apical membrane.38 GLUT1 and GLUT3 are also 
expressed in the cancer cell27 and may also be contributing 
to the detected uptake of sugar, although during differentia-
tion their levels have been shown to decrease. When Caco-2 
cells are cultured in flasks the cells will differentiate between 
days 10-21. During this time a basement (or basolateral) 
membrane will develop and be in contact with the plastic 
flask and the apical membrane will develop and be in contact 
with the media. Tight junctions will also develop effectively 
sealing the apical membrane from the basolateral membrane. 
Measured uptake of glucose is therefore via SGLT1 and 
GLUTs expressed on the apical membrane.
The kinetics of D-glucose uptake into the Caco-2 cells 
was investigated by varying the D-glucose concentrations 
(1 mM, 3 mM, and 6 mM), in the absence or presence of GT 
(0-1 mg/mL). SGLT1 has a Km of 0.1-0.6 mM, GLUT1 and 
GLUT3 a Km of 1-5 mM, and GLUT2 a Km of 15-17 mM
39 
and so the glucose concentration range we used is sufficient 
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to provide a guide to the basis of the inhibition in Caco-2 
cells expressing a mixture of SGLT1 and GLUTs. The Eadie-
Hofstee and Hanes-Wolfe plots (Figure  1A,B) indicated 
clearly that the Km was not affected by the presence of the 
inhibitor indicating that the type of inhibition was non-com-
petitive. The results were also analyzed by non-linear regres-
sion (Figure 1C); however, the limited number of substrate 
concentrations means that the values obtained for the kinetic 
parameters Km and Ki should not be overinterpreted. The ap-
proximate values provided by the non-linear analysis were 
19 mM and 0.022 mg/mL for Km and Ki, respectively. The 
calculated Km is consistent with GLUT2 Km of 15-17 mM, al-
though SGLT1 and other GLUTs will be contributing toward 
the calculated transport of glucose.
The green tea extract (GT), oolong tea extract (OT), 
and black tea extract (BT) all inhibited glucose uptake into 
the intestinal Caco-2 cells in a dose-dependent manner 
(Figure 2). The inhibition curves for GT and OT plateaued 
at the highest tea concentrations suggesting that the inhi-
bition may be partial, that is, some transport activity re-
mains even when the transporters are fully “saturated” with 
respect to the inhibitor. Dixon type plots of GT and OT 
inhibition data became non-linear as the concentration of 
inhibitor increased (data not shown) indicating inhibition 
was partial non-competitive. Whiteley plot analysis of the 
GT and OT data for partial non-competitive inhibition 
(Figure  2A,B inserts) reveals a better fit of the data. In 
contrast, the Dixon type plots of BT inhibition data were 
reasonably linear (Figure 2C insert), which indicated that 
inhibition by black tea is fully non-competitive. The Ki 
and IC50 values (mg/ml) calculated from the various plots 
were, 0.032 and 0.077, 0.057 and 0.136, and 0.36 and 0.56 
for GT, OT, and BT, respectively. Green tea extract is the 
most potent inhibitor of glucose uptake in vitro, followed 
F I G U R E  1  Concentration-dependent uptake of glucose (1-6 mM) by Caco-2 cells in the presence of GT at a concentration of 0 mg/mL (•), 
0.03 mg/mL (◦), 0.15 mg/mL (▼), or 1.0 mg/mL (ᐁ). Caco-2 cells were incubated for 2 minutes in an uptake medium containing 1-6 mM D-[14C] 
glucose at room temperature in the presence of GT. A, Eadie-Hofstee B, Hanes-Wolfe plots, and C, Non-linear regression analysis of glucose 
uptake; data are presented as the mean ± SD (N = 4). Each plot was generated from the mean value of individually fitted parameters. Best fit and 
kinetic constants were obtained from the exploratory kinetics function in SigmaPlot using the non-competitive inhibition (partial) equation
(A) (B)
(C)
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by oolong, and then, black tea. In close agreement with the 
calculated Whiteley and modified Dixon plot data, non-lin-
ear regression analysis of the GT, OT, and BT yielded IC50s 
equal to 0.0438  mg/mL (SE 0.0069), 0.0522  mg/mL (SE 
0.009), and 0.9839 mg/mL (SE 0.53), respectively. The dif-
ferences in Ki found for the various tea types is consistent 
with likely loss of certain inhibitory compounds during 
preparation of black tea.
3.2 | Effects of tea extract on sugar uptake 
into oocytes injected to express SGLT1 and 
facilitative sugar transporters (GLUTs)
Caco-2 cells express SGLT1 and GLUTs38 and is therefore 
a mixed kinetic/transporter model of the human enterocyte. 
To study the effects of tea extracts on individual small intes-
tinal sugar transporters, we used the Xenopus Laevis oocyte 
system. In oocytes injected to express SGLT1, D-glucose 
uptake was enhanced when compared to non-injected sham 
oocytes (Figure 3A) indicating functional expression of the 
SGLT1 transporter protein in the plasma membrane. As ex-
pected, phlorizin (PZ), the classic inhibitor of Na+-dependent 
glucose transport completely abolished D-glucose uptake 
in SGLT1-injected oocytes but had no effect on D-glucose 
uptake in sham oocytes. DMSO (1%), the solvent used to 
dissolve tea extracts, did not significantly affect D-glucose 
uptake into sham or SGLT1 injected oocytes, indicating the 
solvent had minimal effect on diffusion or SGLT1 transport 
activity. Green tea inhibited SGLT1 mediated D-glucose up-
take when compared to D-glucose alone, but not in the pres-
ence of 1% of DMSO (the true control) (Figure 3B). Black 
tea had no effect on SGLT1 mediated D-glucose uptake in 
the presence of 1% of DMSO or its absence (D-glucose). 
Thereafter, the effects of tea extracts on sugar uptake were 
compared against 1% of DMSO.
F I G U R E  2  Effect of tea extracts on D-[14C] glucose uptake in Caco-2 cells. Caco-2 cells were preincubated with green (Figure 2A), oolong 
(Figure 2B) or black tea (Figure 2C) extracts for 10 minutes, then, incubated for 2 minutes in an uptake medium containing 1 mM D-[14C] glucose 
at room temperature in the presence of GT, OT, or BT. GT and OT were tested at a range of concentrations of 0 to 1.0 mg/mL and BT were tested 
at a range of concentrations of 0-2.0 mg/mL as indicated in the figure. Best fit curves were plotted in SigmaPlot using the non-linear regression 
analysis equation y = min + (max−min)/1 + (x/IC50)-hillslope. Results are expressed as means ± SD (N = 6). The inserts present data plotted 
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In oocytes injected to express GLUT1, GLUT1 mediated 
D-glucose uptake was inhibited by green and black tea when 
compared to D-glucose uptake in the presence of solvent 
(1% of DMSO) (Figure  3C). Previous studies have shown 
GLUT2 mediated D-glucose transport in oocytes to be poor, 
possibly because GLUT2 has a lower affinity for glucose 
when compared to other GLUTs. Uptake of sugar into oo-
cytes expressing GLUT2 can however be improved by using 
2-deoxy D-glucose, a non-metabolizable glucose analog that 
once inside the cell is rapidly phosphorylated and trapped.40 
F I G U R E  3  Inhibition of sugar transporters by green and black tea extracts (GT and BT, respectively). A, D-glucose uptake into oocytes 
injected to express SGLT1 and sham (non-injected) oocytes. B, SGLT1 mediated D-glucose uptake, calculated by subtraction of sham oocyte 
data from SGLT1 injected oocyte data. Uptake tested in oocytes at 10 minutes with D-[U-14C] glucose (0.5 µCui/mL) and non-labeled D-glucose 
(10 mM). C, GLUT1 mediated D-glucose uptake. D, GLUT2 mediated 2-deoxy D-glucose uptake. E, GLUT2 mediated D-fructose uptake. F, 
GLUT5 mediated D-fructose uptake. Uptake tested in oocytes at 10 minutes with D-[U-14C] fructose (0.5 µCui/mL) and non-labeled D-fructose 
(10 mM). D-glucose: Uptake media without any additional supplement. PZ: Uptake media supplemented with 0.5 mM Phlorizin/1% of DMSO. 
1% DMSO: Uptake media with 1% DMSO. GT and BT: Uptake media with green tea or black tea extracts (1 mg/mL) dissolved in 1% of DMSO. 
B-F are all sham corrected transport data. Sham uptake of 14C D-glucose and 3H D-fructose were approx. 500 pmols/10 minutes and 14C 2-DG 
100-150 pmols/10 minutes *Indicates results are significantly different between the test samples and control at P < .05 level; ** and *** indicate 
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In oocytes injected to express GLUT2, green, and black tea 
inhibited 2-DG and D-fructose uptake (Figure 3D,E, respec-
tively) but only reached statistical significance with black 
teas inhibition of 2-DG. In contrast to GLUT2, D-fructose 
uptake mediated by GLUT5 expressed in oocytes was signifi-
cantly inhibited by green and black teas (Figure 3F).
3.3 | Effect of catechins in tea extracts 
on the glucose uptake in Caco-2 cells
Based on the HPLC analysis of the catechin contents and 
composition of the tea extracts, the dominant polyphenols in 
the tea samples were determined, the results of which are pre-
sented in Table 2. The catechins consisted of EGCG, GCG, 
EGC, GC, ECG, EC, and C, and the total contents in GT, 
OT, and BT were 22.13%, 14.39%, and 2.24%, respectively. 
Furthermore, linear regression analysis showed the capac-
ity of tea extracts to inhibit glucose uptake was significantly 
correlated to total catechin content (r value for IC50 D-[
14C] 
glucose uptake versus total catechin content was −0.959) 
implying that catechins could be the predominant inhibitors 
in tea extracts. The inhibitory capacity of tea extracts also 
showed good correlation with individual catechins, except 
for catechin (r = −0.394). Gallic acid levels in tea extracts 
did not correlate with potency of the extracts to inhibit glu-
cose transport as shown by the positive correlation coeffi-
cient (r = 0.975).
As shown in Figure 4A-D, the inhibitory activity of cate-
chins was observed for eight types of catechins (C, EC, GC, 
EGC, GCG EGCG, CG, and ECG). Inhibition of D-glucose 
uptake into CaCo-2 cells by C, EC, GC, and EGC was weak 
(Figure 4A,B) and so inhibition constants could not be ac-
curately calculated using Dixon plots. However, CG, ECG, 
GCG, and EGCG were more potent inhibitors of glucose 
transport (Figure 4C,D) and so the Ki and IC50 values were 
calculated using the modified Dixon plots.36 Kinetics analy-
sis showed good agreement between the Ki and IC50 values 
suggesting inhibition of uptake by the catechins was pure 
non-competitive. In close agreement with the calculated 
Dixon plot data, SigmaPlot non-linear regression analysis of 
the GCG, EGCG, CG, ECG best fit curves yielded IC50 val-
ues of 0.076, 0.091, 0.0134, and 0.0143 mg/mL, respectively.
3.4 | Effects of black tea polyphenolics  
and polysaccharides on glucose uptake in 
Caco-2 cells
Although GT was the most potent inhibitor of glucose 
transport in Caco-2 cells, BT also inhibited glucose trans-
port despite low levels of catechins. The inhibitory activity 
of BT could be attributed to some other bioactive present, 
such as flavonols, flavones, anthocyanins, phenolic acids, 
and polysaccharides, as previously reported.41,42 In our ex-
periments, tea polysaccharides, cyanidin, pelargonidin, rutin, 
and apigenin had no effect on glucose uptake by Caco-2 cells 
(Figure 5A-C). In 1 mg/mL of our extracts, we estimated that 
tea polysaccharides (1%-3% of the dry tea) and polyphenols 
(<0.15%-0.01% of the dry tea) will be in the range of 0.1-
30 µg/mL, yet, we saw no inhibition by 0.5-3 mg/mL of tea 
polysaccharides or by 25-50 µg/mL of individual polyphenols 
(100 µM) strongly suggesting these low-level compounds are 










Gallic acid 0.20 0.11 0.85 0.975
Gallocatechin (GC) 0.84 0.77 ND NA
Epigallocatechin 
(EGC)
4.64 4.28 ND NA
Catechin (C) 0.77 0.14 0.29 −0.394
Epicatechin (EC) 1.96 1.37 0.48 −0.956
Gallocatechin gallate 
(GCG)
0.53 0.43 ND NA
Epigallocatechin 
gallate (EGCG)
10.64 6.18 0.77 −0.937
Catechin gallate (CG) 0.21 ND ND NA
Epicatechin gallate 
(ECG)
2.54 1.22 0.70 −0.791
Total catechin 22.13 14.39 2.24 −0.959
Note:: ND means not detectable. NA means not applicable. Pearson’s correlation analysis: Correlation 
Coefficient (r).
T A B L E  2  Content of gallic acid and 
catechins in green, oolong, and black tea 
extracts (%) of dry weight and correlation 
coefficients of analyte content versus IC50 
D-[14C] glucose uptake
10 |   NI et al.
(mainly quercetin and myricetin) have been reported to in-
hibit intestinal glucose uptake markedly,33,38 and this was 
also observed in the present study (Figure  5D). However, 
quercetin and myricetin only constitute up to 0.2%-0.4% and 
0.07%-0.2% in tea, respectively, and are poorly soluble in 
water,43 which suggests that they are unlikely to be the pre-
dominant inhibitors in tea.
Phenolic acids are other important active components in 
tea, with 0.5%-1.4% of gallic acid, 0.3% of chlorogenic acid, 
and  ≤0.1% of caffeic acid.43 The investigation by Welsch 
et al showed that caffeic acid and chlorogenic acid inhibited 
sodium-dependent glucose uptake by rat BBM vesicles.44 
We also found caffeic acid and chlorogenic acid could mod-
estly but significantly reduce Caco-2 cell glucose uptake 
(Figure 5E). The catechin content in GT is greater than BT, 
whereas the four theaflavins (TFs) and thearubigins (TRs) are 
higher in BT than in GT.45 A previous study reported that TFs 
inhibit sugar transport while TRs do not show any inhibitory 
activity.22 With regard to TFs, in our studies, theaflavin (TF) 
was found to significantly inhibit glucose uptake by Caco-2 
cells, similar to BT (Figure 5F). In 1 mg/mL of our extracts, 
we estimate TFs will be in the range of 30-60 µg/ml. We used 
77 µg/mL of TFs in our study, suggesting TF plays an import-
ant role in black tea inhibition of glucose transport.
3.5 | Effect of green tea catechins on 
SGLT1 and GLUT2 gene and protein 
expression levels in Caco-2 cells
To evaluate the effect of green tea catechins on glucose 
transporters at a molecular level, gene and protein expres-
sion profiles of SGLT1 and GLUT2 in Caco-2 cells were 
examined by qRT-PCR and Western blotting. As shown in 
Figure 6A,B incubating Caco2 cells with green tea catechins 
for 2 and 24 hours resulted in a significant 50%-75% decrease 
F I G U R E  4  Effect of catechins on D-[14C] glucose uptake in Caco-2 cells. A, Effect of EC and C on glucose uptake. B, Effect of EGC 
and GC on glucose uptake. C, Effect of EGCG and GCG on glucose uptake. D, Effect of ECG and CG on glucose uptake. Caco-2 cells were 
preincubated with catechins for 10 minutes, and then, incubated for 2 minutes in an uptake medium containing 1 mM D-[14C] glucose at room 
temperature in the presence of catechins. The catechins were dissolved in DMSO (0.5%), and then, diluted with KBSS; the tested concentration 
ranges are shown in the figures. Best fit curves were plotted using SigmaPlot for the nonlinear regression analysis equation y = min + (max−
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in SGLT1 mRNA levels. In contrast, SGLT1 protein expres-
sion levels were largely unchanged by green tea catechins 
(Figure  6C,D), although a modest but statistically signifi-
cant decrease was detected after 2 hours incubation with CG 
(27.0%), ECG (23%), and EGCG (20%).
Following a 2  hours incubation with catechins, GLUT2 
gene and protein expression levels were downregulated by 
approximately 40%-50% (Figure 6E,G). In contrast, GLUT2 
gene expression was upregulated 400%-1400% following 
24  hours incubation with catechins (Figure  6F). GLUT2 
protein expression levels were also significantly upregulated 
after 24  hours incubation with catechins but only for CG, 
ECG, GCG, and EGCG exposed cells (Figure 6H).
4 |  DISCUSSION
In this report, we studied the effects of green, black, and oo-
long tea on intestinal sugar transport mediated by the Na+ 
dependent glucose transporter (SGLT1) and the facilitative 
sugar transporters, (GLUT1, 2 and 5). We found that green 
tea, which contained the highest levels of catechins, was the 
most potent inhibitor of intestinal sugar transport via a partial 
non-competitive type of mechanism, that is, it did not lead to 
complete loss of transport activity even at high levels of tea 
extract. The most likely targets for the tea extracts were the 
GLUTs. We also showed that CG and GCG and their epi-
forms were the most potent inhibitors of glucose transport 
F I G U R E  5  Effects of black tea polyphenolics and polysaccharides on D-[14C] glucose uptake in Caco-2 cells. A, Effect of tea 
polysaccharides at a range of concentrations of 0 to 3.0 mg/mL on glucose uptake. B, Effect of cyanidin and pelargonidin at 100 μM on glucose 
uptake. C, Effect of rutin and apigenin at 100 μM on glucose uptake. D, Effect of quercetin, myricetin, ECG, and CG at 50 μM on glucose uptake. 
E, Effect of phenolic acids at 100 μM on glucose uptake. F, Effect of TF (0.077 mg/mL) and BT (0.35 mg/mL) at 100 μM on glucose uptake. 
Caco-2 cells were preincubated with each component, respectively, for 10 minutes, then, incubated for 2 minutes in an uptake medium containing 
1 mM D-[14C] glucose at room temperature in the presence of each component, respectively. KBSS was used as the control; other components 
were dissolved in DMSO (≤0.5%), and then, diluted with KBSS. Results are expressed as means ± SD (N = 4). *Indicates results are significantly 
different between the test samples and control at P < .05 level; NS indicates results are not significantly different between the test samples and 
control at P > .05
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F I G U R E  6  Effect of green tea catechins on mRNA and protein levels of SGLT1 and GLUT2 in Caco-2 cells. A-D, The protein and 
mRNA levels of SGLT1 after 2 or 24 hours of incubation with tea catechins. E-H, The protein and mRNA levels of GLUT2 after 2 or 24 hours 
of incubation with tea catechins. CK: Caco-2 cells were incubated with full culture medium at 37°C; C, EC, CG, ECG, GC, EGC, GCG, and 
EGCG: Caco-2 cells were incubated with 200 µM C, EC, CG, ECG, GC, EGC, GCG, and EGCG. Results are expressed as means ± SD (N = 3). 
C, EC, CG, ECG, GC, EGC, GCG, and EGCG were dissolved in DMSO (≤0.5%), and then, diluted with full culture medium. *Indicates results 
are significantly different between the test samples and control at P < .05 level; NS indicates results are not significantly different between the test 
samples and control at P > .05
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activity. Selected catechins were also able to reduce SGLT1 
and GLUT2 gene and protein expression levels.
Green tea is a non-fermented tea, and in its manufacture 
the primary goal is to preserve leaf catechins. Indeed, in this 
report, we showed the catechin content of GT was the highest 
of all the teas sampled, at 21.9% of total dry matter. During 
black tea manufacture, there is a high degree of enzyme-cat-
alyzed aerobic oxidation (fermentation) of the leaf polyphe-
nols followed by a series of chemical condensation reactions, 
which result in a significant decrease of catechins (3%-10% 
of dry weight) and production of theaflavins and thearubigins 
(3%-6% and 12%-18%, respectively). Oolong tea is partially 
fermented, and so catechin content is intermediate between 
green and black teas (8%-20% of the total dry matter).46 In 
Caco-2 cells, inhibition of glucose transport by the tea ex-
tracts was in the following order: GT > OT > BT, and our 
inhibitory data (IC50 values) for D-[
14C] glucose uptake 
showed a significant correlation with the catechin content of 
teas, thus, providing strong evidence that tea catechins inhibit 
the small intestinal sugar transporters.
Previous studies have shown strawberries and blackber-
ries rich in polyphenolics such as anthocyanins can inhibit 
intestinal glucose transport in isolated cells and in human 
dietary intervention studies.47,48 Our in vitro data suggest 
that teas have the potential to inhibit the facilitative glucose 
transporters (eg, GLUTs) in the small intestine, which may 
attenuate postprandial glycemic responses in humans. These 
findings may also have clinical utility because it is known 
that in obesity and diabetes, GLUT1 and GLUT2 are over 
expressed in the apical membrane of enterocyte contributing 
toward enhanced glucose absorptive capacity.25,49,50 In ad-
dition, intestinal GLUT1 expression is enhanced in inflam-
matory bowel disease (IBD)51 and in cancers,52 and high 
intakes of dietary fructose is associated with increased risk 
of non-alcoholic fatty liver disease (NAFLD).53 Our tea ex-
tracts, and in particular our green tea extract, could be used 
as a concentrated source of polyphenolics (catechins) that 
in beverage form may be used in the dietary management of 
T2DM to lower the rise in postprandial blood glucose con-
centrations, improve insulin sensitivity and glycemic control 
in the long-term via inhibition of small intestinal GLUTs.
To identify the individual tea catechins that inhibit intesti-
nal glucose transport, we studied eight catechins (C, EC, CG, 
ECG, GC, EGC, GCG, and EGCG) at concentrations ranging 
between 0.01 and 0.1 mg/mL (20-200 µM) and showed that 
the potency of glucose-uptake inhibition was in the order: 
CG > ECG > EGCG ≥ GCG > C > EC > GC > EGC. These 
data are consistent with previous findings showing ECG to be 
the most potent inhibitor of glucose transport.23,33 Although 
the mechanisms by which tea catechins inhibit glucose up-
take are currently unclear, their structural characteristics 
(as shown in Figure 7) may be important in three possible 
ways: (1) esterification affects glucose uptake, so that gal-
lated catechin (ie, CG) is more inhibitory than the non-gal-
lated structure (ie, C); (2) the –OH group on R2 of the B ring 
affects glucose uptake, with the non-hydroxylated structure 
(ie, ECG) being more inhibitory than hydroxylated catechin 
(ie, EGCG); (3) the trans-catechin isomer (ie, CG) is more in-
hibitory than the cis-catechin form (ie, ECG), but this differ-
ence was not observed in the geometric isomers EGCG and 
GCG. Pharmaceutical companies could use this information 
to develop drug treatments to alleviate postprandial hypergly-
cemia in the diabetic population. Individual catechins could 
also be used as nutraceuticals for inclusion in functional in-
gredients and foods/drinks to improve glycemic control.
The non-competitive inhibition of glucose uptake by cat-
echins shown in our study suggests the aglycone catechins 
(eg, ECG and EGCG) do not interfere with the sugar binding 
F I G U R E  7  Structures of eight catechins
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sites of the facilitative transporters. This is consistent with 
previous reports, which have shown that the aglycone phlore-
tin non-competitively inhibits GLUTs, whereas the glycone 
phlorizin competitively inhibits SGLT1.54 Indeed, ECG 
and EGCG are the major tea catechins and have a triphe-
nol structure, which is reported to bind to the lipid bilayers 
with high affinity and to perturb the membrane structure.55 
Polyphenolics have also been shown to inhibit intracellular 
glucose metabolism.56 Catechins could therefore inhibit in-
ternal glucose metabolism, leading to a build-up of intracel-
lular glucose, which in turn could dampen facilitative glucose 
transport. We believe this to be an unlikely explanation of our 
data since uptake of the non-metabolizable glucose analog, 
2-deoxy D-glucose, in GLUT2 expressing oocytes was inhib-
ited by tea extracts. The mechanisms by which catechins and 
other polyphenolics enter the cell are also unclear. Previous 
work has shown that quercetin was not transported into oo-
cytes injected to express GLUT238 and that ECG was not 
transported into rabbit intestinal BBMVs.23
It has been reported that ECG and EGCG, but not catechin, 
competitively inhibit SGLT1 mediated 100  nM D-glucose 
uptake into rabbit BBM vesicles23 and also that ECG and 
EGCG non-competitively inhibited Na+ currents in the pres-
ence of 0.5 mM D-glucose in oocytes expressing SGLT1.57 
In the current study there was no evidence of tea extracts 
inhibiting glucose uptake into oocytes expressing SGLT1, 
because the competitive inhibition of SGLT1-mediated glu-
cose transport (Km 0.1-0.6 mM)
39 by 1 mg/mL of teas con-
taining ECG (2.5% of dry weight) and EGCG (10% of dry 
weight) would most likely be overwhelmed by the 10 mM 
of D-glucose concentration used in our transport assays. In 
addition, tea catechins are potent non-competitive inhibitors 
of Na+/K+-ATPase,1,58 which might explain the reduction in 
Na+ currents detected in an earlier report.
Thus far, we and others have shown that teas and tea cat-
echins can inhibit intestinal sugar transporters in the short-
term. It has also been reported that tea catechins can impact 
intestinal sugar transporter capacity in the long-term by alter-
ing gene expression levels.59 In this study, rats treated with 
green tea for 6 weeks displayed significantly reduced SGLT1 
and increased GLUT2 mRNA level in the jejunum mucosa.59 
We also found that SGLT1 gene expression was down-reg-
ulated in Caco-2 cells following 2- and 24-hours exposure 
to individual tea catechins; however, SGLT1 protein expres-
sion was only modestly reduced when exposed to CG, GCG, 
and EGCG for 2 hours. This discordance in gene and protein 
expression levels may reflect differing half-lives of the gene 
and protein and suggests that the blood glucose lowering 
properties of tea catechins over the postprandial period are 
not mediated via changes in small intestinal SGLT1 protein 
expression levels. The effects of individual tea catechins on 
GLUT2 gene and protein expression levels were also much 
more complicated with gene and protein expression levels 
being modestly reduced after 2 hours exposures to catechins 
but increased at 24 hours. Over the postprandial period tea 
catechins may inhibit glucose absorption via reductions in 
GLUT2 protein at the basolateral and apical membrane.60 In 
the long-term, and perhaps because the cells are starved of 
fuel (glucose), GLUT2 gene and protein expression levels are 
upregulated. This however may not be physiologically rele-
vant, because ingested polyphenolics are rapidly metabolized 
by the gut and liver.61 Further studies in vitro and in animal 
models are necessary to determine the short- and long-term 
effects of teas on intestinal sugar transport capacity via alter-
ations in sugar transporter gene and protein expression levels.
In conclusion, we report that tea extracts and individual 
tea catechins strongly inhibit small intestinal sugar transport-
ers. This is likely to be a key mechanism along with other 
physiological effects of tea polyphenols, such as inhibition of 
starch digestion,16 increased insulin sensitivity and/or insulin 
secretion62 in explaining improvements in glucose tolerance 
in experimental animals62 and humans.41 Similar proof of 
principle studies in Caco-2 cells and in oocytes have been 
undertaken by other laboratories using berry extracts and 
have provided information on the mechanisms that underpin 
the effects of berries on postprandial glycemia in people.45,46 
Based on these findings, tea plants genetically engineered 
to enhance their CG or ECG content could be generated by 
plant breeders for the food industry and be used as nutraceu-
ticals to reduce the glycemic index of foods and beverages, 
blunting postprandial blood glucose responses and providing 
the consumer with a healthier dietary choice.
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